article thumbnail

Unlocking the potential of mRNA for the future treatment of rare diseases 

Drug Discovery World

mRNA enables the delivery of a transiently expressed genetic molecule that is translated into a target protein using the machinery of the host cell. Finally, dosing and timing may be controlled simply by adjusting the amount of mRNA delivered to the cells, rather than relying on inducible systems that are integrated into the genome.

article thumbnail

AI test could predict best cancer therapies for patients

pharmaphorum

The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking at changes to 52 proteins when they are exposed to a panel of targeted anticancer drugs. The post AI test could predict best cancer therapies for patients appeared first on.

Protein 67
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity This on-demand webinar introduces a cutting-edge single-cell multiomics method designed for garnering detailed genetic insights into breast cancer. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.

Hormones 115
article thumbnail

What to expect from SLAS Europe 2023

Drug Discovery World

SLAS Student Poster Award The SLAS Student Poster Award recognises innovative research by students, graduate students, post- doctoral associates and junior faculty (less than four years in first academic appointment) who are chosen to present a poster during SLAS Europe 2023.

Doctors 52